Article Text

other Versions

Serum S100A12 as a new marker for inflammatory bowel disease and its relationship with disease activity
  1. Dirk Foell
  1. Correspondence to Professor Dirk Foell, University Children's Hospital Muenster, Albert-Schweitzer-Str. 33, Muenster 48149, Germany; dfoell{at}

Statistics from

The Author's response We read the letter by Brinar et al published online first with interest.1 The authors of this letter confirm elevated S100A12 serum concentrations in inflammatory bowel disease but they could not find a correlation between disease activity and S100A12 serum levels. The differences to our study published in 2003 can be easily explained by the ELISA systems used in the different studies. Brinar …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles